Effects of corticosteroid, montelukast and iNOS inhibition on distal lung with chronic inflammation

Respiratory Physiology and Neurobiology

Volumn 185, Issue 2, 2013, Pages 435-445

  Souza, Flávia Castro Ribas ^a   Gobbato, Nathália Brandão ^a   Maciel, Rafaela Guerra ^a   Prado, Carla Máximo ^a,b   Martins, Mílton Arruda ^a   Leick, Edna A ^a   Tibério, Iolanda F L Calvo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Asthma; Chronic airway inflammation; Corticosteroids; Experimental models of asthma; INOS; Leukotriene antagonists

Indexed keywords

ACTIN; DEXAMETHASONE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 4; INTERLEUKIN 5; MONTELUKAST; OVALBUMIN; PROSTAGLANDIN F2; PROSTAGLANDIN F2 ALPHA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; ELASTIC FIBER; ENZYME INHIBITION; EXTRACELLULAR MATRIX; MALE; MORPHOMETRICS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ACETATES; AMIDINES; ANIMALS; ANTI-INFLAMMATORY AGENTS; BENZYLAMINES; CHRONIC DISEASE; CYTOKINES; DEXAMETHASONE; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; EOSINOPHILS; GUINEA PIGS; LUNG; MALE; OVALBUMIN; PNEUMONIA; QUINOLINES; STATISTICS, NONPARAMETRIC;

EID: 84871920031     PISSN: 15699048     EISSN: 18781519     Source Type: Journal    
DOI: 10.1016/j.resp.2012.08.015     Document Type: Article

References (42)

1. Amlani S., Nadarajah T., McIvor R.A. Montelukast for the treatment of asthma in the adult population. Expert Opinion on Pharmacotherapy 2011, 12(13):2119-2128. (review).
2. Angeli P., Prado C.M., Xisto D.G., Silva P.L., Pássaro C.P., Nakazato H.D., Leick-Maldonado E.A., Martins M.A., Rocco P.R., Tibério I.F. Effects of chronic l-NAME treatment lung tissue mechanics, eosinophilic and extracellular matrix responses induced by chronic pulmonary inflammation. American Journal of Physiology. Lung Cellular and Molecular Physiology 2008, 294(6):L1197-L1205.
3. Barnes P.J. Biochemical basis of asthma therapy. Journal of Biological Chemistry 2011, 286(38):32899-32905. (review).
4. Bonsignore M.R., La Grutta S., Cibella F., Scichilone N., Cuttitta G., Interrante A., Marchese M., Veca M., Virzi' M., Bonanno A., Profita M., Morici G. Effects of exercise training and montelukast in children with mild asthma. Medicine and Science in Sports and Exercise 2008, 40(3):405-412.
5. De Magalhães S.S., Dos Santos M.A., da Silva O.M., Fontes E.S., Fernezlian S., Garippo A.L., Castro I., Castro F.F., Martins A.M., Saldiva P.H., Mauad T., Dolhnikoff M. Inflammatory cell mapping of the respiratory tract in fatal asthma. Clinical and Experimental Allergy 2005, 35:602-611.
6. Global Initiative for Asthma Global Strategy for Asthma Management and Prevention Program. National Heart, Lung, and Blood Institute/World Health Organization. Workshop Report 2011, U.S. Department of Health, Education, and Welfare, Washington, Available from:, (accessed 2011). http://www.ginasthma.org/.
7. Goleva E., Hauk P.J., Boguniewicz J., Martin R.J., Leung D.Y. Airway remodeling and lack of bronchodilator response in steroid-resistant asthma. Journal of Allergy and Clinical Immunology 2007, 120(5):1065-1072.
8. Henderson W.R., Tang L.-I., Chu S.-J., Tsao S.-M., Chiang G.K.S., Jones F., Jonas M., Pae C., Wang H., Chi E.Y. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. American Journal of Respiratory and Critical Care Medicine 2002, 165:108-116.
9. Holgate S.T., Peters-Golden M., Panettieri R.A., Henderson W.R. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. Journal of Allergy and Clinical Immunology 2003, 111(1 Suppl.):S18-S34.
10. Jartti T. Inhaled corticosteroids or montelukast as the preferred primary long-term treatment for pediatric asthma?. European Journal of Pediatrics 2008, 167(7):737-738.
11. Joos S., Miksch A., Szecsenyi J., Wieseler B., Grouven U., Kaiser T., Schneider A. Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review. Thorax 2008, 63(5):453-462. (review).
12. Lanças T., Kasahara D.I., Prado C.M., Tibério I.F.L.C., Martins M.A., Dolhnikoff M. Comparison of early and late responses to antigen of sensitized guinea pig parenchymal lung strips. Journal of Applied Physiology 2006, 100(5):1610-1616.
13. Leick-Maldonado E.A., Kay F.U., Leonhardt M.C., Kasahara D.I., Prado C.M., Fernandes F.T., Martins M.A., Tibério I.F.L.C. Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in an experimental model of chronic airway inflammation in guinea-pigs. Clinical and Experimental Allergy 2004, 34:145-152.
14. Luna L.G. AFIP Manual of Histologic Staining Methods 1986, McGraw-Hill, New York.
15. Martin R.J. Exploring the distal lung: new direction in asthma. Israel Medical Association Journal 2008, 10(12):846-849.
16. McMillan S.J., Lloyd C.M. Prolonged allergen challenge in mice leads to persistent airway remodelling. Clinical and Experimental Allergy 2004, 34(3):497-507.
17. McMillan S.J., Xanthou G., Lloyd C.M. Therapeutic administration of budesonide ameliorates allergen-induced airway remodelling. Clinical and Experimental Allergy 2005, 35(3):388-396.
18. Miller M., Cho J.Y., McElwain K., McElwain S., Shim J.Y., Manni M., Baek J.S., Broide D.H. Corticosteroids prevent myofibroblast accumulation and airway remodeling in mice. American Journal of Physiology. Lung Cellular and Molecular Physiology 2006, 290(1):L162-L169.
19. Morrow J.D. The isoprostanes - unique products of arachidonate peroxidation: their role as mediators of oxidant stress. Current Pharmaceutical Design 2006, 12(8):895-902. (review).
20. Nakashima A.S., Prado C.M., Lanças T., Ruiz V.C., Kasahara D.I., Leick-Maldonado E.A., Dolhnikoff M., Martins M.A., Tibério I.F. Oral tolerance attenuates changes in in vitro lung tissue mechanics and extracellular matrix remodeling induced by chronic allergic inflammation in guinea pigs. Journal of Applied Physiology 2008, 104(6):1778-1785.
21. National Institutes of Health/Health Research Extension Act of 1985, Public Law 99-158, November 20, 1985. " Animals in Research" U.S. Government Principles for the Utilization and Care of Vertebrate Animals Used in Testing, Research, and Training Public Health Service Policy on Humane Care and Use of Laboratory Animals. http://grants.nih.gov/grants/olaw/references/phspol.htm.
22. Naura A.S., Zerfaoui M., Kim H., Abd Elmageed Z.Y., Rodriguez P.C., Hans C.P., Ju J., Errami Y., Park J., Ochoa A.C., Boulares A.H. Requirement for inducible nitric oxide synthase in chronic allergen exposure-induced pulmonary fibrosis but not inflammation. Journal of Immunology 2010, 185(5):3076-3085.
23. Offer S., Shoseyov D., Bibi H., Eliraz A., Madar Z. A leukotriene receptor antagonist modulates iNOS in the lung and in a leukotriene-free cell model. Nitric Oxide 2003, 9:10-17.
24. Prado C.M., Leick-Maldonado E.A., Arata V., Kasahara D.I., Martins M.A., Tibério I.F.L.C. Neurokinins and inflammatory cell iNOS expression in guinea pigs with chronic allergic airway inflammation. American Journal of Physiology. Lung Cellular and Molecular Physiology 2005, 288(4):L741-L748.
25. Prado C.M., Leick-Maldonado E.A., Kasahara D.I., Capelozzi V.L., Martins M.A., Tibério I.F. Effects of acute and chronic nitric oxide inhibition in an experimental model of chronic pulmonary allergic inflammation in guinea pigs. American Journal of Physiology. Lung Cellular and Molecular Physiology 2005, 289(4):L677-L683.
26. Prado C.M., Leick-Maldonado E.A., Yano L., Leme A.S., Capelozzi V.L., Martins M.A., Tibério I.F.L.C. Effects of nitric oxide synthases in chronic allergic airway inflammation and remodeling. American Journal of Respiratory Cell and Molecular Biology 2006, 35(4):457-465.
27. Prado C.M., Leick E.A., Lopes F.D.T.Q.S., Martins M.A., Tibério I.F.L.C. Different modulators of airways and distal lung parenchyma contractile responses in the physiopathology of asthma. Current Basic and Pathological Approaches to the Function of Muscle Cells and Tissues - From Molecules to Humans 2012, 1-30. InTech - Open Access Publisher, Rijeka-Croatia, (Chapter 13). 1st ed. Haruo Sug, InTech - Open Access Publisher (Org.) (Eds.).
28. Price D., Musgrave S.D., Shepstone L., Hillyer E.V., Sims E.J., Gilbert R.F., Juniper E.F., Ayres J.G., Kemp L., Blyth A., Wilson E.C., Wolfe S., Freeman D., Mugford H.M., Murdoch J., Harvey I. Leukotriene antagonists as first-line or add-on asthma-controller therapy. New England Journal of Medicine 2011, 364(18):1695-1707.
29. Pryor W.A., Squadrito G.L., Friedman M. The cascade mechanism to explain ozone toxicity: the role of lipid ozonation products. Free Radical Biology and Medicine 1995, 19(6):935-941. (review).
30. Ramos-Barbón D., Parra-Arrondo A. Inflammation and remodeling of the distal airways: studies in humans and experimental models. Archivos de Bronconeumologia 2011, 47(2):2-9.
31. Ricciardolo F.L., Nijkamp F.P., Folkerts G. Nitric oxide synthase (NOS) as therapeutic target for asthma and chronic obstructive pulmonary disease. Current Drug Targets 2006, 7(6):721-735.
32. Seco A.J., Salgueiro M.E., Manso G. Acute and chronic treatment with glucocorticosteroids, modifying the beta 2-adrenergic response of the guinea pig trachea. Lung 1995, 173(5):321-328.
33. Starling C.M., Prado C.M., Leick-Maldonado E.A., Lanças T., Reis F.G., Aristóteles L.R., Dolhnikoff M., Martins M.A., Tibério I.F. Inducible nitric oxide synthase inhibition attenuates lung tissue responsiveness and remodeling in a model of chronic pulmonary inflammation in guinea pigs. Respiratory Physiology and Neurobiology 2009, 165(2-3):185-194.
34. Stelmach I., Jerzynska J., Kuna P. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma. Journal of Allergy and Clinical Immunology 2002, 109(2):257-263.
35. Sugiura H., Komaki Y., Koarai A., Ichinose M. Nitrative stress in refractory asthma. Journal of Allergy and Clinical Immunology 2008, 121(2):355-360.
36. Tibério I.F.L.C., Leick-Maldonado E.A., Miyahara L., Kasahara D.I., Spilborghs G.M.G.T., Saldiva P.H.N., Martins M.A. Effects of neurokinins on airway and alveolar eosinophil recruitment. Experimental Lung Research 2003, 29:167-177.
37. Tibério I.F.L.C., Turco G.M.G., Leick-Maldonado E.A., Sakae R.S., Paiva P.S.O., Warth M.P.T.N., Lapa e Silva J.R., Saldiva P.H.N., Martins M.A. Effects of neurokinin depletion on airway inflammation induced by chronic antigen exposure. American Journal of Respiratory and Critical Care Medicine 1997, 155:1739-1747.
38. Walker G., Pfeilschifter J., Kunz D. Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon (IFN)-gamma-stimulated RAW 264.7 cells by dexamethasone. Evidence for glucocorticoid-induced degradation of iNOS protein by calpain as a key step in post-transcriptional regulation. Journal of Biological Chemistry 1997, 272(26):16679-16687.
39. Watanabe T., Okano M., Hattori H., Yoshino T., Ohno N., Ohta N., Sugata Y., Orita Y., Takai T., Nishizaki K. Roles of FcgammaRIIB in nasal eosinophilia and IgE production in murine allergic rhinitis. American Journal of Respiratory and Critical Care Medicine 2004, 169:105-112.
40. Weibel E.R. The challenge of measuring lung structure. On the " Standards for the quantitative assessment of lung structure" Nihon Kokyuki Gakkai Zasshi 2010, 48(9):637-643.
41. Yuan Y., Wang Z., Dong B. Modulation of matrix metalloproteinase by dexamethasone in airway remodeling in asthmatic rats. Sichuan Da Xue Xue Bao Yi Xue Ban 2003, 34(4):680-683.
42. Zar J.H. Biostatistical Analysis 1984, Prentice-Hall Inc., Englewood Cliffs, pp. 206-235. 2nd ed.